Giampietro Sgaragli

Prof. Dr. Giampietro Sgaragli


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
SSSimona Saponara
Simona Saponara
GSGiampietro Sgaragli
Giampietro Sgaragli
FFFabio Fusi
Fabio Fusi

1 February 2003 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
FFFabio Fusi
Fabio Fusi
SSSimona Saponara
Simona Saponara
FPFederica Pessina
Federica Pessina
BGBeatrice Gorelli
Beatrice Gorelli
GSGiampietro Sgaragli
Giampietro Sgaragli

1 March 2016 in Biochemical Pharmacology
Verified
Journal Article
Closed access
OKOnat Kadioglu
Onat Kadioglu
MSMohamed E.M. Saeed
Mohamed E.M. Saeed
MVMassimo Valoti
Massimo Valoti
Maria FrosiniMaria Frosini
Maria Frosini
GSGiampietro Sgaragli
Giampietro Sgaragli
Thomas EfferthThomas Efferth
Thomas Efferth

4 May 1999 in Experimental Brain Research
Verified
Journal Article
Closed access
PDF file
Maria FrosiniMaria Frosini
Maria Frosini
CSCasilde Sesti
Casilde Sesti
MVMassimo Valoti
Massimo Valoti
MPMitri Palmi
Mitri Palmi
FFFabio Fusi
Fabio Fusi
GSGiampietro Sgaragli
Giampietro Sgaragli

1 January 2016 in Vascular Pharmacology
Verified
Journal Article
Closed access
FFFabio Fusi
Fabio Fusi
Fabrizio ManettiFabrizio Manetti
Fabrizio Manetti
MDMiriam Durante
Miriam Durante
GSGiampietro Sgaragli
Giampietro Sgaragli
Simona SaponaraSimona Saponara
Simona Saponara

5 September 2016 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
GSGiampietro Sgaragli
Giampietro Sgaragli
Maria FrosiniMaria Frosini
Maria Frosini
Mycobacterium tuberculosis (M. tuberculosis), an almost genetically monomorphic pathogen is a human parasite, transmitted mostly by humans and causes tuberculosis (TB). TB is firmly associated to poverty, although lack of proper nutrition and lowered immune status are contributing factors for disease development. TB remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent and is responsible for nearly 1.5 million deaths annually. Some steps of the progress of our knowledge of M. tuberculosis physiology and its interactions with human beings, are reviewed here. This progress has provided fertile ground for improving diagnosis and cure of TB infection. For TB diagnostics laboratories in high-burden countries, primary isolation is the first step before performing drug susceptibility testing (DST) of M. tuberculosis. IGRA (interferon-γ release assay)-based tests for diagnosis of active TB are sufficiently fast, specific and sensitive to allow to contain infection and distinguish among latent TB infection and BCG vaccination individuals from those who have clinically resolved M. tuberculosis infection after anti-TB treatment.